Evaluation and treatment of malignant ascites secondary to gastric cancer

doi:10.3748/wjg.v21.i39.10936

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 39

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13402)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

919

WORD

238

HTML

7578

Figures (1-2)

180

Tables (1-3)

196

Sum=9111

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

567

Download

1168

Sum=1735

Publishing Process of This Article

Item

Count

Browse

1061

Download

1495

Sum=2556

Oct 21, 2015 (publication date) through Jul 26, 2024

Times Cited of This Article

Times Cited (57)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Oct 21, 2015; 21(39): 10936-10947
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.10936

Full Size Figure Download Figure

Figure 2 Clinical benefit response in gastric cancer. CBR-GC is defined by the ascites response to treatment (horizontal axis) and ECOG-PS (vertical axis). Response of ascites is judged by a combination of abdominal girth and treatment intensity. CBR-GC: Clinical benefit response in gastric cancer; ECOG-PS: Eastern Cooperative Oncology Group performance status.

Citation: Maeda H, Kobayashi M, Sakamoto J. Evaluation and treatment of malignant ascites secondary to gastric cancer. World J Gastroenterol 2015; 21(39): 10936-10947
URL: https://www.wjgnet.com/1007-9327/full/v21/i39/10936.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i39.10936